New York Life Investment Management’s Oracle ORCL Stock Holding History
Bought
Maintained
Sold
Other funds holding ORCL
VCM
VPM
New York Life Investment Management's ORCL Position: Q1 2026 in Review
New York Life Investment Management increased its Oracle (ORCL) stake by 2.2% in Q1 2026, buying an estimated $825K and bringing the position to 236,152 shares worth $34.7M. The position accounts for 0.29% of the portfolio, ranked #64.
New York Life Investment Management first reported a position in ORCL in Q2 2022 and has held it in 16 quarters since. The position peaked at $63.8M in Q3 2025. 3,475 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.
- New York Life Investment Management held 236,152 shares of Oracle worth $34.7M as of Q1 2026.
- New York Life Investment Management bought 5,078 Oracle shares in Q1 2026, an estimated $825K.
- Oracle made up 0.29% of New York Life Investment Management's portfolio in Q1 2026, its #64 holding.
- New York Life Investment Management first reported a position in Oracle in Q2 2022 and has held it in 16 quarters since.
- New York Life Investment Management's Oracle position peaked at $63.8M in Q3 2025.
- 3,475 funds tracked by Wall St. Rank held Oracle as of Q1 2026.
Based on New York Life Investment Management's 13F filing for Q1 2026, filed 7 May 2026.